CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection

dc.creatorTavares, Luciana P.
dc.creatorGarcia, Cristiana C.
dc.creatorMachado, Marina G.
dc.creatorQueiroz Junior, Celso M.
dc.creatorBarthelemy, Adeline
dc.creatorTrottein, François
dc.creatorSiqueira, Marilda Agudo Mendonça Teixeira de
dc.creatorBrandolini, Laura
dc.creatorAllegretti, Marcello
dc.creatorMachado, Alexandre M.
dc.creatorSousa, Lirlândia P. de
dc.creatorTeixeira, Mauro M.
dc.date2018-02-10T18:58:52Z
dc.date2018-02-10T18:58:52Z
dc.date2017
dc.date.accessioned2023-09-27T00:15:28Z
dc.date.available2023-09-27T00:15:28Z
dc.identifierTAVARES, Luciana P. et al. CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection. Frontiers in Immunology, v. 8, p. 1-14, Dec. 2017.
dc.identifier1664-3224
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/24796
dc.identifier10.3389/fimmu.2017.01799
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8899029
dc.descriptionInfluenza A infections are a leading cause of morbidity and mortality worldwide especially when associated with secondary pneumococcal infections. Inflammation is important to control pathogen proliferation but may also cause tissue injury and death. CXCR1/2 are chemokine receptors relevant for the recruitment of neutrophils. We investigated the role of CXCR1/2 during influenza, pneumococcal, and post-influenza pneumococcal infections.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFrontiers Media
dc.rightsopen access
dc.subjectInflamação
dc.subjectImunomodulação
dc.subjectVírus da Influenza A
dc.subjectStreptococcus pneumoniae 
dc.subjectCoinfecção 
dc.subjectinflammation
dc.subjectimmunomodulation
dc.subjectcXcr1/2
dc.subjectinfluenza A
dc.subjectpneumococcus
dc.subjectsecondary infection
dc.titleCXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection
dc.typeArticle


Este ítem pertenece a la siguiente institución